Innovative Industrial Properties Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? Innovative Industrial Properties Inc trades at $51.88 (market cap $1.43B), while Roivant Sciences Ltd. Common Shares trades at $35.1 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 17.3× Innovative Industrial Properties Inc's market cap, and Innovative Industrial Properties Inc pays a 14.64% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Innovative Industrial Properties Inc for 86 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| IIPR | ROIV | |
|---|---|---|
Market Cap | $1.43B | $24.72B |
Volume | 394,222 | 6,279,442 |
Sector | Real Estate | Health |
52-Week High | $64.67 | $41.81 |
52-Week Low | $44.58 | $16.04 |
Typical Hold Time | 86 Days | 0 Days |
Enterprise Value | $1.96B | $20.99B |
Dividend Yield | 14.64% | — |
Signals from Pluang's Aura AI — not financial advice
IIPR trades at $52.36, up 2.21% today, with a bearish technical signal but oversold RSI readings. The company reported a Q2 2026 EPS beat of $1.36 versus $1.02 expected, though revenue declined to $266M in 2025. Valuation metrics appear attractive with a P/E of 11.75 and P/B of 0.83, while a recent $245 million mezzanine loan commitment signals active capital deployment.
The outlook balances a high dividend yield near 13% against tenant default risks and declining operating cash flow. Analyst consensus is mixed with a $84.67 price target, but the stock faces headwinds from sector volatility and earnings inconsistency, requiring careful risk assessment for income-focused investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →